BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

SUSAN G KOMEN FOR THE CURE — Lobbying — Receipts Report

LD-2 disclosure · 1st Quarter - Report

SUSAN G KOMEN FOR THE CURE

via FOLEY HOAG LLP

1st Quarter (Jan 1 - Mar 31) · 2009Posted Apr 20, 2009Filing document ↗LDA record ↗

Income$60Kfee reported

Client

Name: SUSAN G KOMEN FOR THE CURE
Location: * Undetermined

Registrant

Firm: FOLEY HOAG LLP
Description: Law firm
Location: Washington, District of Columbia, United States of America

Lobbying activities

1 issue

Health Issues
Matters affecting research, diagnosis, treatment and prevention of breast cancer, including 21st Century Cancer Alert Act
LobbyistsNICK LITTLEFIELD · THOMAS GRISSOM · PAUL KIM · KALAH AUCHINCLOSS · KELLY CHILDRESS
Covered position (THOMAS GRISSOM): Director of Center for Medicare Management
Covered position (KELLY CHILDRESS): Congressman Rogers Staff; Congressman Shimkus, Staff
TargetedSENATE · HOUSE OF REPRESENTATIVES · Health & Human Services, Dept of (HHS)

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.